Iovance Biotherapeutics Inc (IOVA)

[GMH*]

Another interesting article published yesterday. Should not that Angeles Clinic and Research Institute is currently NOT an ATC.

https://www.cancernetwork.com/view/tumor-infiltrating-lymphocyte-therapy-advances-into-melanoma

Another article from Oncologist at Cooper Health (NJ). They are both a P3 trial site and also recently approved ATC. Comments are interesting in that I was concerned about P3 cannibalizing Commercial patients, but as noted, eligibility requirements probably will limit that. This is unfortunate for patients and hopefully patients will become aware of TIL prior to ICI treatment in the future, but for now, at least there is an L2+ option.

https://www.roi-nj.com/2024/04/18/healthcare/til-then-cooper-doctor-is-excited-to-bring-novel-melanoma-treatment-to-south-jersey-region/